Fortune: A $200 debit card won’t put a dent in seniors’ drug costs
During our transition, where to find information about:
- Our merged organization: uniting.patientadvocate.org
- Financial assistance: totalassist.org
- Additional direct patient services and resources: patientadvocate.org
- Education: panfoundation.org and education.patientadvocate.org
- Clinical trials education: clinicaltrials.panfoundation.org
- Advocacy: npaf.org
- Research: patientinsightinstitute.org
Policy experts say that what Medicare beneficiaries really need are sweeping federal changes to close the gap between what their health insurance pays and what drugs cost them. PAN Foundation President and CEO Dan Klein comments on how the Trump administration’s proposal to provide $200 debit cards to seniors would be better served focusing on people with serious illnesses who have high out-of-pocket drug costs.